2000
DOI: 10.1002/1529-0131(200002)43:2<281::aid-anr7>3.0.co;2-7
|View full text |Cite
|
Sign up to set email alerts
|

Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis

Abstract: Objective. To compare synovial fluid (SF) levels of oncostatin M (OSM), tumor necrosis factor (TNF), and interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to determine which correlate best with SF levels of antigenic keratan sulfate (Ag KS), a marker of aggrecan catabolism, and pyridinium crosslinks, markers of the degradation of mature collagen molecules. Methods. SF was drawn from the knee joints of patients with RA (n 31) or OA (n 31). Levels of Ag KS, D-pyridinolin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
74
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 122 publications
(83 citation statements)
references
References 35 publications
9
74
0
Order By: Relevance
“…Elevated levels of OSM have been found at sites of inflammation, and OSM has been shown to regulate the expression of other inflammatory mediators such as IL-6. 35,36 In that respect and in the light of our results presented here it should also be emphasized that OSM as well as C5a have been recently implicated in the pathology of inflammatory joint destruction. 37,38 Thus we hypothesize that this link between the complement system and the gp130 receptor cytokine family might potentially impact on the pathology of inflammatory disease.…”
Section: Discussionsupporting
confidence: 60%
“…Elevated levels of OSM have been found at sites of inflammation, and OSM has been shown to regulate the expression of other inflammatory mediators such as IL-6. 35,36 In that respect and in the light of our results presented here it should also be emphasized that OSM as well as C5a have been recently implicated in the pathology of inflammatory joint destruction. 37,38 Thus we hypothesize that this link between the complement system and the gp130 receptor cytokine family might potentially impact on the pathology of inflammatory disease.…”
Section: Discussionsupporting
confidence: 60%
“…Both IL-1 and OSM alone have been reported to induce joint inflammation and cartilage destruction in vitro and in vivo, and elevated levels of these two cytokines in synovial fluid of RA patients correlate with disease activity and destruction of cartilage and bone. [2][3][4][5]7,8 The present study demonstrates for the first time that IL-1 in combination with OSM induces marked joint inflammation, synovial hyperplasia, pannus formation, and cartilage/bone destruction in a murine model, which are all hallmarks of the pathological changes seen in RA. Specifically, this combination causes dramatic proteoglycan and collagen loss as reported previously in cartilage explant studies, 7,17 and this is associated with elevated levels of MMP expression.…”
Section: Discussionsupporting
confidence: 55%
“…OSM has been localized to the macrophages within RA synovium, 7 and elevated synovial fluid levels of OSM 7,8 correlate with markers of joint inflammation and cartilage destruction in RA. 2 In experimental animals, intraarticular delivery of human OSM or recombinant adenovirus vectors overexpressing murine OSM (AdmOSM) cause synovial inflammation and structural damage. 9 -11 Blockade of OSM ameliorates joint inflammation and cartilage damage in collagen-induced arthritis.…”
mentioning
confidence: 99%
“…1). Joint aspirates from human patients with arthritis often contain wear particles, for example, collagen, proteoglycan, bone, uric acid, fibronectin, crystals and other, as yet unidentified, materials (Evans et al, 1984;Xie et al, 1992;Lohmander et al, 1993Lohmander et al, , 1994Manicourt et al, 2000;Nalbant et al, 2003). Some of these wear particles have also been identified in the SF of dogs with arthropathy (Arican et al, 1994;Innes et al, 1998;Chu et al, 2002).…”
Section: Humoral Immunity In Cruciate Diseasementioning
confidence: 99%